ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681645; 2) Community: the network communities that were significantly associated with the response to NSC 681645; 3) Molecule: the relationships between components within communities and NSC 681645; 4) MDR: the compounds that were significantly associated with the NSC 681645.

NSC Compound Enrichment Correlation
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.000610795106687085 0.6856667
NSC 681640 Camptothecin Derivative 0.000967118311825486 0.8937644
NSC 681642 Camptothecin Derivative 0.000967118311825486 0.9450489
NSC 166237 Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) 0.00104257542638397 0.62933413
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00104257542638397 0.72218994
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.00104257542638397 0.78674646
NSC 606172 Camptothecin Derivative 0.00104257542638397 0.85911325
NSC 606985 Camptothecin Derivative 0.00104257542638397 0.80131149
NSC 618939 Camptothecin Derivative 0.00104257542638397 0.90348112
NSC 623520 Null 0.00104257542638397 0.29257338
Total:67  Current:5    [First] [Prev] [Next] [Last]